Diligence memo · auto-generated · as of July 2, 2026

Health Outcomes Sciences, Inc.

Health Outcomes Sciences, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Health Outcomes Sciences, Inc. operates in Healthtech, based in PHOENIX.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Health Outcomes Sciences, Inc. has raised $16M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $13M on 2014-03-04.

Most recent recorded round closed around 2019-04-30.

Valuation (modeled)modeled

Provath models Health Outcomes Sciences, Inc. at approximately $23M (range $1.3M–$123M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.19× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 31 months.

Last raise 7.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.9× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 76% of Healthtech peers (2138 compared).

Modeled value ranks above 47% of those peers.

Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.